Dolutegravir Uptake In Women Still Trails That In Men In Low- And Middle-Income Countries, Large Study Suggests

MedPage Today (11/30, Lei Wu) reports, “In low- and middle-income countries, dolutegravir (Tivicay) uptake in women still trailed that in men months after a safety reaffirmation from the World Health Organization (WHO), a large study showed.” According to...